# GLP-1s and sleep apnea: Zepbound's OSA approval · PepVault

Source: https://pepvault.app/guides/glp-1-and-sleep-apnea

Last updated: 2026-11-20

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Guides](https://pepvault.app/guides) [GLP-1s](https://pepvault.app/guides#glp1)

# GLP-1s and sleep apnea: Zepbound's OSA approval

Reviewed November 2026 12 sources [Published by PepVault](https://pepvault.app/guides/how-we-research)

Zepbound is the one drug approved for sleep apnea. The SURMOUNT-OSA results, how fast it works, CPAP, and where semaglutide stands, as of November 2026.

- **Last reviewed:** Nov 20, 2026
- **Sources:** 12
- **Questions:** 8
- **Compounds:** 4

## The short answer

One drug is approved for sleep apnea: Zepbound (tirzepatide), since December 2024, for moderate to severe obstructive sleep apnea in adults with obesity. In its two 52-week trials, breathing events fell by half or more, 25 to 29 an hour against about 5 on placebo, and 42 to 50% reached remission or mild, symptom-free disease. No semaglutide brand carries this approval. Keeping CPAP is your prescriber's call.

Every number checked at its primary source · Nov 20, 2026 · [12 sources](https://pepvault.app/guides/glp-1-and-sleep-apnea#sources) · [How we research](https://pepvault.app/guides/how-we-research)

**Evidence:** Strong for tirzepatide: two phase 3 randomized, placebo-controlled trials built for sleep apnea (469 adults, 52 weeks). Moderate for liraglutide (one 32-week phase 3 trial) and early for retatrutide (a 243-person subgroup of one phase 3 trial); semaglutide has no dedicated sleep apnea trial published.

## Which GLP-1 is approved for sleep apnea?

Only Zepbound. On December 20, 2024, the FDA approved it to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity, alongside a reduced-calorie diet and more physical activity, and called it the first drug treatment option for certain patients with the condition[2](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-2). The current label, revised August 2026, keeps that **indication** (the use a drug is approved for) beside its weight-loss one[1](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-1). Obstructive sleep apnea is breathing that stops or turns shallow again and again during sleep because the throat closes; it is graded by the **apnea-hypopnea index (AHI)**, the number of those events per hour in an overnight sleep study. The label's "moderate to severe" means an AHI of 15 or more, and the trials enrolled people with a BMI of 30 or more[1](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-1).

Tirzepatide is not a pure GLP-1 drug: it switches on two gut-hormone receptors, GIP and GLP-1[1](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-1). Mounjaro is the same molecule, but its label covers type 2 diabetes and heart risk in diabetes, not sleep apnea[12](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-12). Wegovy (semaglutide) and Saxenda (liraglutide) are approved for weight, and Wegovy also for heart risk and a fatty-liver disease; neither label names sleep apnea[7](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-7) [11](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-11).

A second kind of drug may follow. In July 2026 the FDA accepted Apnimed's application for AD109, an oral pill that combines aroxybutynin and atomoxetine and works on the throat muscles rather than on weight; the FDA's target date for a decision is February 28, 2027, and until then it stays investigational[10](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-10).

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Turn on a dose reminder and PepVault nudges you on your weekly shot day, at the time you set, until the dose is logged; each logged dose stays in your history, so every four-week step is easy to see.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What did the SURMOUNT-OSA trials find?

SURMOUNT-OSA was two **double-blind** trials run side by side, 469 adults in all, with an average BMI of about 39 and an average AHI of about 50, so most had severe disease[3](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-3). Trial 1 enrolled people not using a breathing machine at night; trial 2 enrolled people already on positive airway pressure (PAP, the CPAP mask and pump). People with type 2 diabetes were left out[1](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-1). Each person climbed from 2.5 mg to the highest weekly dose they tolerated, 10 or 15 mg, or got a placebo, for 52 weeks[3](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-3). The table gives the week-52 results, tirzepatide against placebo[1](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-1) [3](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-3).

| At week 52 | Trial 1: no PAP | Trial 2: on PAP |
| --- | --- | --- |
| Starting AHI, events per hour | 51.5 | 49.5 |
| Change in AHI, events per hour | −25.3 vs −5.3 | −29.3 vs −5.5 |
| Change in AHI, percent | −50.7% vs −3.0% | −58.7% vs −2.5% |
| AHI cut by half or more | 61.2% vs 19.0% of people | 72.4% vs 23.3% |
| Remission or mild, symptom-free OSA | 42.2% vs 15.9% | 50.2% vs 14.3% |
| Body weight | −17.7% vs −1.6% | −19.6% vs −2.3% |
| Systolic blood pressure (week 48), mm Hg | −9.5 vs −1.8 | −7.6 vs −3.9 |

Where the average person started and ended in SURMOUNT-OSA: from severe to the edge of moderate on tirzepatide.

"Remission or mild, symptom-free" is the label's own phrase for an AHI under 5, or an AHI of 5 to 14 with an Epworth sleepiness score of 10 or less (a daytime-sleepiness questionnaire scored 0 to 24)[1](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-1). The trials' authors note that at those levels a PAP machine may no longer be recommended[3](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-3). People in trial 2 stopped their machine for 7 days before each sleep study, so its numbers show breathing without the mask[3](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-3). Tirzepatide also lowered the oxygen dips during the night, a marker of inflammation (hsCRP), and how impaired and disturbed people rated their sleep[3](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-3).

## How does a weight-loss drug ease sleep apnea?

Mostly through the weight it takes off. Excess body fat is a major risk factor for obstructive sleep apnea, and one that can be reversed[3](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-3), and the FDA wrote that Zepbound's improvement in AHI is likely related to the weight lost[2](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-2). A later analysis of both trials found that the people who lost more weight had larger drops in AHI and in the night's oxygen dips[4](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-4). The working picture is that less fat around the neck and airway leaves the throat less likely to fall shut when the muscles relax in sleep; a 2026 review calls that the most likely explanation, while noting it has not yet been confirmed by imaging the airway of people on these drugs[8](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-8).

Whether tirzepatide does anything for breathing beyond the weight is still open: the authors of that analysis say more research is needed to separate the two[4](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-4).

## With this guide

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Mixing charts

- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)
- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)

### Studies

- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)
- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)

### Compared with

- [Retatrutide vs Tirzepatide](https://pepvault.app/peptides/compare/retatrutide-vs-tirzepatide)
- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Mazdutide vs Tirzepatide](https://pepvault.app/peptides/compare/mazdutide-vs-tirzepatide)
- [Tirzepatide vs Liraglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-liraglutide)
- [Tirzepatide vs Dulaglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-dulaglutide)
- [Orforglipron vs Tirzepatide](https://pepvault.app/peptides/compare/orforglipron-vs-tirzepatide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [Maintenance dose](https://pepvault.app/glossary/maintenance-dose)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [GIP](https://pepvault.app/glossary/gip)
- [Glucagon](https://pepvault.app/glossary/glucagon)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Indication](https://pepvault.app/glossary/indication)
- [Double-blind](https://pepvault.app/glossary/double-blind)
- [Post hoc analysis](https://pepvault.app/glossary/post-hoc-analysis)

## How fast does Zepbound work for sleep apnea?

Over months, not nights. CPAP holds the airway open from the first night; a drug works as weight comes off. The label's climb starts at 2.5 mg a week for four weeks and steps up 2.5 mg at a time, at least four weeks apart, to a maintenance dose of 10 or 15 mg for sleep apnea, with 15 mg the maximum[1](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-1). In the trials that climb took up to 20 weeks[3](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-3). These are the label's and the trials' schedules, not a dose for any one person.

The dose climb ends by week 20, the same week the gap against placebo became clear.

In trial 1, a home sleep device showed AHI falling from each person's own starting point as early as week 4, but the gap against placebo was not clear until week 20[4](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-4). The full result was measured at week 52[3](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-3). That analysis was planned after the main results (a **post hoc analysis**), so it describes the timing rather than proving it.

<!--promo-->

Turn on a dose reminder and PepVault nudges you on your weekly shot day, at the time you set, until the dose is logged; each logged dose stays in your history, so every four-week step is easy to see. [Set reminders in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-glp-1-and-sleep-apnea-inline&mt=8)

<!--/promo-->

## Does Zepbound replace CPAP?

Not on the label. Its words are plain: the sleep apnea trials did not evaluate the timing or appropriateness of stopping PAP in people who were using it well[1](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-1). What the trials do show is that the drug worked with or without a machine: in PAP users, measured with the mask off, 50.2% reached remission or mild disease, against 42.2% in people not using one (two separate trials, not compared with each other)[1](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-1) [3](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-3). Even so, about half of the people on tirzepatide in trial 2, and more than half in trial 1, did not reach that level[1](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-1).

So the drug and the machine answer different needs: the machine treats every night it is worn, and the drug works on the weight that narrows the airway. Whether to treat sleep apnea with a drug, and whether to keep the CPAP once breathing improves, is a decision for you and your prescriber or sleep clinic, usually after a repeat sleep study.

**When to get help** Dozing off while driving, or a partner noticing long pauses in your breathing again, is a reason to call your sleep clinic soon.

## What about semaglutide, liraglutide and retatrutide?

Other drugs in the family have sleep apnea data, but none has the approval. Semaglutide (Wegovy, Ozempic) has no published randomized trial built for sleep apnea; a 2026 review of the evidence names liraglutide and tirzepatide as the only drugs in the class with direct sleep apnea trials, and calls semaglutide's data indirect, from its obesity trials[8](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-8). The table puts the trials that do exist side by side.

| Drug | Trial | Change in AHI, events per hour | Weight | Approved for OSA? |
| --- | --- | --- | --- | --- |
| Tirzepatide (Zepbound) | SURMOUNT-OSA, 469 adults, 52 weeks[3](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-3) | −25.3 and −29.3 vs about −5 on placebo | −17.7% and −19.6% | Yes, December 2024[2](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-2) |
| Liraglutide 3.0 mg (Saxenda) | SCALE Sleep Apnea, 359 adults, 32 weeks[5](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-5) | −12.2 vs −6.1 | −5.7% vs −1.6% | No[11](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-11) |
| Retatrutide 4, 9 and 12 mg | TRIUMPH-1 subgroup, 243 adults, 80 weeks[6](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-6) | −22.9, −34.3 and −31.7 vs −9.9 | Whole trial: −17.6%, −23.7% and −25.0% vs −3.9% | No: not an approved drug |
| Semaglutide (Wegovy) | No dedicated sleep apnea trial published[8](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-8) | — | — | No[7](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-7) |

More weight lost, fewer breathing events: the pattern across the three drugs with sleep apnea data.

The pattern follows weight. Liraglutide took off about 6% and cut AHI by about 6 events an hour more than placebo; in its trial, too, more weight lost went with more improvement[5](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-5). Retatrutide, a Lilly drug that adds a third receptor, glucagon, had larger AHI drops than tirzepatide's at its 9 and 12 mg doses, but over 80 weeks rather than 52 and in a different trial with a larger placebo drop, and no trial has compared them head to head. It is not an approved drug, and its sleep apnea result comes from 243 people inside a larger weight trial, which is weaker evidence than a trial built for sleep apnea[6](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-6).

## What side effects came up in the sleep apnea trials?

The same stomach effects as in the weight trials, mostly mild to moderate and mostly during the dose climb[3](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-3). The label states that the side effects in the sleep apnea trials were similar to those in the weight-loss trials[1](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-1). On tirzepatide, against placebo, in trial 1 and trial 2[3](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-3):

- **Diarrhea:** 26.3% and 21.8%, against 12.5% and 8.8%.
- **Nausea:** 25.4% and 21.8%, against 10.0% and 5.3%.
- **Vomiting:** 17.5% and 9.2%, against 4.2% and 0.9%.
- **Constipation:** 15.8% and 15.1%, against 2.5% and 4.4%.
- **Stopped because of a side effect:** 4.4% and 3.4%, against 1.7% and 7.0%.

What helps in the step-up weeks is ordinary: smaller meals, eating slowly and stopping at the first sign of fullness. The full list of side effects and warnings is on the tirzepatide side effects page and in the label[1](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-1).

**Commonly reported:** in users' own accounts, not trial measures, quieter nights and less snoring as the weight comes off, waking more rested within a few months, and nausea or fullness for a day or two after each dose step.

## What happens to sleep apnea if you stop Zepbound?

No trial has measured it yet. SURMOUNT-OSA treated people for 52 weeks and did not follow their breathing after the drug stopped[3](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-3). What is known is what happens to the weight, which the trials tied to the breathing. In SURMOUNT-4, a weight trial rather than a sleep apnea one, people who lost 20.9% over 36 weeks on tirzepatide and were then switched to placebo regained 14.0% of their body weight over the next year, while those who stayed on it lost another 5.5%[9](https://pepvault.app/guides/glp-1-and-sleep-apnea#source-9). If the airway improvement rides on the weight, it is a fair guess, not a measured result, that it slips as the weight returns; a repeat sleep study is how you would know.

<!--promo-->

PepVault keeps your weigh-ins on one chart and your doses in the log, so the weight change the trials tied to fewer breathing events is ready for your next sleep or weight visit. [Track your weight in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-glp-1-and-sleep-apnea-inline&mt=8)

<!--/promo-->

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-next&mt=8)

<!--/promo-->

## Sources

1. Zepbound (tirzepatide) injection, prescribing information. Eli Lilly and Company. DailyMed, revised August 2026 (SPL version 40). [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b)
2. U.S. Food and Drug Administration. FDA approves first medication for obstructive sleep apnea. Press announcement, December 20, 2024. [fda.gov](https://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-obstructive-sleep-apnea)
3. Malhotra A et al. Tirzepatide for the treatment of obstructive sleep apnea and obesity. N Engl J Med. 2024;391(13):1193-1205. [PubMed 38912654](https://pubmed.ncbi.nlm.nih.gov/38912654/)
4. Malhotra A et al. Tirzepatide for sleep-disordered breathing in SURMOUNT-OSA: time course and association with body weight. Sleep Med. 2025;136:106853. [PubMed 41135142](https://pubmed.ncbi.nlm.nih.gov/41135142/)
5. Blackman A et al. Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial. Int J Obes (Lond). 2016;40(8):1310-1319. [PubMed 27005405](https://pubmed.ncbi.nlm.nih.gov/27005405/)
6. Jastreboff AM et al. Retatrutide, a triple hormone receptor agonist, for treatment of obesity (TRIUMPH-1). N Engl J Med. 2026;395(18):1781-1793. [PubMed 42814954](https://pubmed.ncbi.nlm.nih.gov/42814954/)
7. Wegovy (semaglutide) injection and tablets, prescribing information. Novo Nordisk. DailyMed, published June 30, 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b)
8. Zhang X et al. Incretin-based therapies in obesity-related obstructive sleep apnea: a narrative review of evidence tiers and mechanistic plausibility. Nat Sci Sleep. 2026;18:611573. [PubMed 42591103](https://pubmed.ncbi.nlm.nih.gov/42591103/)
9. Aronne LJ et al. Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial. JAMA. 2024;331(1):38-48. [PubMed 38078870](https://pubmed.ncbi.nlm.nih.gov/38078870/)
10. Apnimed. Apnimed announces FDA acceptance of New Drug Application for AD109, an investigational oral pill to treat adults with obstructive sleep apnea. Press release, July 14, 2026. [prnewswire.com](https://www.prnewswire.com/news-releases/apnimed-announces-fda-acceptance-of-new-drug-application-for-ad109-an-investigational-oral-pill-to-treat-adults-with-obstructive-sleep-apnea-osa-302825008.html)
11. Saxenda (liraglutide) injection, prescribing information. Novo Nordisk. DailyMed. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143)
12. Mounjaro (tirzepatide) injection, prescribing information. Eli Lilly and Company. DailyMed. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0)

<!--promo-->

Newsletter · Weekly

## The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

<!--/promo-->

## Next guide · GLP-1

Guide · GLP-1

### [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)

Retatrutide's first dose in its trials: the 2 mg start, how long one shot lasts, when appetite and stomach effects showed up, and the first-shot routine.

Read the next guide

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## In the library

- [Tirzepatide Studied range: 2.5–15 mg](https://pepvault.app/peptides/tirzepatide)
- [Semaglutide Studied range: 0.25–2.4 mg](https://pepvault.app/peptides/semaglutide)
- [Liraglutide Studied range: 0.6–3 mg](https://pepvault.app/peptides/liraglutide)
- [Retatrutide Studied range: 1–12 mg](https://pepvault.app/peptides/retatrutide)

## Related guides

- Guide · GLP-1s

  ### [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)

  What to expect on tirzepatide week by week: the label's dose steps, when appetite and nausea change, weight loss from week 20 to year 3, and the plateau.

  Read the guide
- Guide · GLP-1s

  ### [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)

  Tirzepatide doses from 2.5 to 15 mg: the Mounjaro and Zepbound label steps, the 4-week rule, maintenance doses, pens and vials, and SURMOUNT-1 weight by dose.

  Read the guide
- Guide · GLP-1s

  ### [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)

  What happened to weight when semaglutide and tirzepatide were stopped in STEP 1, STEP 4 and SURMOUNT-4: how much came back, how fast, and what the labels say.

  Read the guide
- Guide · GLP-1s

  ### [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)

  Mounjaro and Zepbound side effects at 5, 10 and 15 mg against placebo, from the labels' trial tables: when they show up, how many stopped, and what helps.

  Read the guide

## Guides

- [All guides](https://pepvault.app/guides)
- [How we research](https://pepvault.app/guides/how-we-research)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this guide

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Mixing charts

- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)
- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)

### Studies

- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)
- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)

### Compared with

- [Retatrutide vs Tirzepatide](https://pepvault.app/peptides/compare/retatrutide-vs-tirzepatide)
- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Mazdutide vs Tirzepatide](https://pepvault.app/peptides/compare/mazdutide-vs-tirzepatide)
- [Tirzepatide vs Liraglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-liraglutide)
- [Tirzepatide vs Dulaglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-dulaglutide)
- [Orforglipron vs Tirzepatide](https://pepvault.app/peptides/compare/orforglipron-vs-tirzepatide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [Maintenance dose](https://pepvault.app/glossary/maintenance-dose)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [GIP](https://pepvault.app/glossary/gip)
- [Glucagon](https://pepvault.app/glossary/glucagon)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Indication](https://pepvault.app/glossary/indication)
- [Double-blind](https://pepvault.app/glossary/double-blind)
- [Post hoc analysis](https://pepvault.app/glossary/post-hoc-analysis)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
